302 related articles for article (PubMed ID: 16533694)
1. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
Cheung C; Luo H; Yanagawa B; Leong HS; Samarasekera D; Lai JC; Suarez A; Zhang J; McManus BM
Cardiovasc Pathol; 2006; 15(2):63-74. PubMed ID: 16533694
[TBL] [Abstract][Full Text] [Related]
2. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction.
Li J; Schwimmbeck PL; Tschope C; Leschka S; Husmann L; Rutschow S; Reichenbach F; Noutsias M; Kobalz U; Poller W; Spillmann F; Zeichhardt H; Schultheiss HP; Pauschinger M
Cardiovasc Res; 2002 Nov; 56(2):235-47. PubMed ID: 12393094
[TBL] [Abstract][Full Text] [Related]
3. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
5. Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Cheung C; Marchant D; Walker EK; Luo Z; Zhang J; Yanagawa B; Rahmani M; Cox J; Overall C; Senior RM; Luo H; McManus BM
Circulation; 2008 Mar; 117(12):1574-82. PubMed ID: 18332263
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis.
Meng XH; Wang Y; Zhuang JX; Han XZ; Chen Y; Jin YP; Wang YL; Yu YH; Spires JP; Song GJ
Chin Med J (Engl); 2004 Aug; 117(8):1195-9. PubMed ID: 15361294
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system.
Rutschow S; Leschka S; Westermann D; Puhl K; Weitz A; Ladyszenskij L; Jaeger S; Zeichhardt H; Noutsias M; Schultheiss HP; Tschope C; Pauschinger M
Eur J Pharmacol; 2010 Mar; 630(1-3):145-51. PubMed ID: 20035743
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Pauschinger M; Rutschow S; Chandrasekharan K; Westermann D; Weitz A; Peter Schwimmbeck L; Zeichhardt H; Poller W; Noutsias M; Li J; Schultheiss HP; Tschope C
Eur J Heart Fail; 2005 Jun; 7(4):444-52. PubMed ID: 15921778
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1.
Crocker SJ; Frausto RF; Whitmire JK; Benning N; Milner R; Whitton JL
Am J Pathol; 2007 Dec; 171(6):1762-73. PubMed ID: 18055551
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis.
Cheung CT; Deisher TA; Luo H; Yanagawa B; Bonigut S; Samra A; Zhao H; Walker EK; McManus BM
Lab Invest; 2007 Jul; 87(7):651-61. PubMed ID: 17468777
[TBL] [Abstract][Full Text] [Related]
15. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
16. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
Guenzinger R; Lahm H; Wottke M; Lange R
ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
19. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C
Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
